Search

everythinglearnresearchcommunity

for

Search:↓

Farudodstat may help prevent hair loss in alopecia areata by stopping immune attacks on hair follicles.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Zinc may help treat alopecia areata by boosting certain immune cells.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

γδ T cells are essential for wound healing after poxvirus infection.

Stem cells help control the immune response to improve wound healing.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Targeting Interleukin-13 could help treat alopecia areata linked with atopic dermatitis.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

IL-27 can prevent hair loss in alopecia areata.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Most HIV-positive patients had skin problems, and conditions like oral thrush and boils were linked to weaker immune systems.

Neutrophils are important for causing chronic itch in atopic dermatitis, and blocking the CXCR3 receptor may reduce this itch.

HPV8 causes hair follicle stem cells to grow, leading to skin lesions.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

A man with HIV developed skin and hair issues after starting HIV treatment, which improved with topical treatment.

Lower MC2R expression may contribute to alopecia areata.

Thymosin beta 4 protects cells from damage by blocking a harmful microRNA and boosting a protective gene.

T-cell patterns in skin help distinguish alopecia areata from androgenetic alopecia.

Belatacept may be a promising treatment for alopecia areata.

Increased T cell activity may predict hair regrowth success with minoxidil in severe alopecia areata.

Next-generation Treg therapies could help achieve lasting immune tolerance in type 1 diabetes.

Relatives of lupus patients show signs of immune system activity but not full-blown lupus.